Sorrento Therapeutics, Inc. 13D and 13G filings for Scilex Holding Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-26 4:49 pm Sale | 2023-09-21 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 1,917,210 1.300% | -93,616,299 (-97.99%) | Filing |
| 2023-08-14 8:59 pm Unchanged | 2023-08-07 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 95,533,509 43.300% | 0 (Unchanged) | Filing |
| 2023-03-03 09:10 am Unchanged | 2023-02-21 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 95,533,509 44.200% | 0 (Unchanged) | Filing |
| 2023-01-23 4:33 pm Sale | 2023-01-19 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 95,533,509 45.500% | -72,354,178 (-43.10%) | Filing |
| 2022-11-17 5:09 pm Purchase | 2022-11-10 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 167,887,687 96.300% | 167,887,687 (New Position) | Filing |